Azerbaijani clinicians primarily use metformin and sulfonylureas to manage Type 2 diabetes. These first-line treatments improve insulin sensitivity and stimulate insulin production. JCI-accredited facilities in Baku, such as Liv Bona Dea Hospital, also provide GLP-1 and SGLT-2 inhibitors.
- Metformin therapy: Standard first-line medication used to lower glucose production.
- Sulfonylureas: Includes Gliclazide and Glimepiride to help the pancreas produce insulin.
- Specialist care: Endocrinologists like Dr Lamiya Nabibayli manage complex metabolic cases.
- Specialised options: Major centres offer DPP-4, SGLT2, and GLP-1 receptor agonists.
Bookimed Expert Insight: Metformin is the national standard. However, leading Baku clinics often use integrative approaches. Dr Lamiya Nabibayli at Biological Medicine Center combines traditional endocrinology with German-influenced methods. This focus on metabolic syndrome and obesity often leads to personalised medication protocols.
Patient Consensus: Patients in Azerbaijan note that metformin is the most familiar option. Many suggest checking the local availability of specific insulin types before arriving.